Novel Glycosaminoglycan Precursors as Anti-Amyloid Agents Part II

By Kisilevsky Robert   Szarek Walter A.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 45-50

Humana Press, Inc

Access to resources Recommend Favorite

Novel glycosaminoglycan precursors as anti-amyloid agents, Part III

By Kisilevsky Robert   Szarek Walter   Ancsin John   Bhat Shridhar   Li Zhanjiang   Marone Sandra  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 291-297

Humana Press, Inc

Access to resources Recommend Favorite

The molecular mechanisms of the anti-amyloid effects of phenols

By Shoval Hila   Lichtenberg Dov   Gazit Ehud  

Amyloid: The Journal of Protein Folding Disorders, Vol. 14, Iss. 1, 2007-01 ,pp. : 73-87

Informa Healthcare

Access to resources Recommend Favorite

Parkinson's disease, insulin resistance and novel agents of neuroprotection

By Aviles-Olmos Iciar  

Brain, Vol. 136, Iss. 2, 2013-02 ,pp. : 374-384

Oxford University Press

Access to resources Recommend Favorite

Alzheimer's disease: the glycosaminoglycan sink

By Briani C.   Cagnin A.   Pizzolato G.  

Lancet Neurology, Vol. 2, Iss. 12, 2003-12 ,pp. : 723-723

Elsevier

Access to resources Recommend Favorite